BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23029122)

  • 1. Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.
    Waterman RS; Henkle SL; Betancourt AM
    PLoS One; 2012; 7(9):e45590. PubMed ID: 23029122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
    Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
    PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats.
    Wang L; Li P; Tian Y; Li Z; Lian C; Ou Q; Jin C; Gao F; Xu JY; Wang J; Wang F; Zhang J; Zhang J; Li W; Tian H; Lu L; Xu GT
    Curr Mol Med; 2017; 17(6):421-435. PubMed ID: 29210653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Cell-Based Therapy Paradigm: Induction of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells into Pro-Inflammatory MSC1 and Anti-inflammatory MSC2 Phenotypes.
    Betancourt AM
    Adv Biochem Eng Biotechnol; 2013; 130():163-97. PubMed ID: 22869086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy.
    Waterman RS; Morgenweck J; Nossaman BD; Scandurro AE; Scandurro SA; Betancourt AM
    Stem Cells Transl Med; 2012 Jul; 1(7):557-65. PubMed ID: 23197860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological appraisal of human bone marrow mesenchymal stem cells during ex-vivo expansion].
    Xia WJ; Xu R; Ye X; Fu YS; Luo GP; Ding HQ; Xiang P; Zhang XM; Deng J; Chen YK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):639-44. PubMed ID: 18549645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation.
    Deng L; Li H; Su X; Zhang Y; Xu H; Fan L; Fan J; Han Q; Bai X; Zhao RC
    Cell Death Dis; 2020 Mar; 11(3):158. PubMed ID: 32123161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells.
    Lei J; Hui D; Huang W; Liao Y; Yang L; Liu L; Zhang Q; Qi G; Song W; Zhang Y; Xiang AP; Zhou Q
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2431-43. PubMed ID: 23911306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic Features of Mesenchymal Stem Cell Subpopulations Obtained under the Influence of Various Toll-Like Receptors Ligands.
    Shoshina OO; Kozhin PM; Shadrin VS; Romashin DD; Rusanov AL; Luzgina NG
    Bull Exp Biol Med; 2021 Feb; 170(4):555-559. PubMed ID: 33725247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the induction of anti-inflammatory mesenchymal stem cells and their application in the treatment of immune-related nephropathy.
    Zhou C; Bai XY
    Front Med (Lausanne); 2022; 9():891065. PubMed ID: 36059816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE.
    Kurte M; Vega-Letter AM; Luz-Crawford P; Djouad F; Noël D; Khoury M; Carrión F
    Stem Cell Res Ther; 2020 Sep; 11(1):416. PubMed ID: 32988406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?
    Klopp AH; Gupta A; Spaeth E; Andreeff M; Marini F
    Stem Cells; 2011 Jan; 29(1):11-9. PubMed ID: 21280155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity.
    Rahmani Kukia N; Alipanah-Moghadam R; Delirezh N; Mazani M
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1895-1902. PubMed ID: 30049202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis.
    He T; Huang Y; Zhang C; Liu D; Cheng C; Xu W; Zhang X
    Oncotarget; 2017 Nov; 8(57):96993-97008. PubMed ID: 29228588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization.
    Suzuki K; Sun R; Origuchi M; Kanehira M; Takahata T; Itoh J; Umezawa A; Kijima H; Fukuda S; Saijo Y
    Mol Med; 2011; 17(7-8):579-87. PubMed ID: 21424106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Inhibitory Effect of Mesenchymal Stem Cells with rAd-NK4 on Liver Cancer.
    Cai C; Hou L; Zhang J; Zhao D; Wang Z; Hu H; He J; Guan W; Ma Y
    Appl Biochem Biotechnol; 2017 Sep; 183(1):444-459. PubMed ID: 28353041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passage-dependent accumulation of somatic mutations in mesenchymal stromal cells during in vitro culture revealed by whole genome sequencing.
    Kim M; Rhee JK; Choi H; Kwon A; Kim J; Lee GD; Jekarl DW; Lee S; Kim Y; Kim TM
    Sci Rep; 2017 Nov; 7(1):14508. PubMed ID: 29109420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
    Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
    Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
    Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
    Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
    Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.